All In Biotech

Free tool

FAERS Monitor: Nallpen In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050655 or its brand name (Nallpen In Plastic Container, Nafcillin Sodium). Reports on generic versions are filed under their own applications.

Reports

710

Serious

618

87% of reports

Hospitalization

362

Death reported

98

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective52
  • acute kidney injury48
  • rash44
  • tubulointerstitial nephritis39
  • hypokalaemia38
  • renal failure35
  • renal failure acute35
  • pyrexia34
  • drug interaction32
  • anxiety25
  • drug hypersensitivity25
  • nephropathy toxic24
  • pain24
  • blood creatinine increased23
  • diarrhoea23

Reports by year received

View as table
YearReports
20047
200511
200610
200915
201034
201133
201244
201336
201456
201535
201635
201746
201842
201959
202058
202141
202248
202340
202418
202522
202620

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,449 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nephropathy toxicSignal2463.542.81,412
tubulointerstitial nephritisSignal3961.845.52,269
renal failure acuteSignal3524.517.7765
hypokalaemiaSignal3824.417.9831
blood creatinine increasedSignal2310.47.0188
acute kidney injurySignal489.37.1349
renal failureSignal357.85.7202
drug interactionSignal326.04.3129
drug hypersensitivitySignal253.82.650
rashSignal443.02.258
pyrexiaSignal342.92.141
anxietySignal252.61.823
drug ineffective521.20.91
pain241.20.80
diarrhoea231.10.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.